Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Natco Pharma Ltd.
NSE: NATCOPHARM
|
BSE: 524816
|
ISIN: INE987B01026
|
Industry: Pharmaceuticals
|
Mid-range Performer
917.0000
-12.85
(
-1.38
%)
NSE
Jul 31, 2026
15:55 PM
25.25% Fall from 52W High
Volume:
329.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Natco Pharma Ltd.
20 Aug 2024
917.00
-1.38%
NATCO PHARMA
Accumulate:
Natco Pharma Ltd.
by
Geojit BNP Paribas
Target: 1597
Target
Geojit BNP Paribas
Number of FII/FPI investors increased from 285 to 298 in Jun 2026 qtr.
More from Natco Pharma Ltd.
Recommended
Market closes higher, led by gains in finance and auto stocks
Trendlyne Marketwatch |
31 Jul 2026, 04:09PM
India's chemical makers move into higher-value products, new industries
The Baseline |
31 Jul 2026, 03:28PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
|
18 Jun 2020